Prestige Consumer Healthcare Inc.
PBH · NYSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $1,137,762 | $1,125,357 | $1,127,725 | $1,086,812 |
| % Growth | 1.1% | -0.2% | 3.8% | – |
| Cost of Goods Sold | $503,299 | $500,909 | $502,431 | $466,166 |
| Gross Profit | $634,463 | $624,448 | $625,294 | $620,646 |
| % Margin | 55.8% | 55.5% | 55.4% | 57.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $108,209 | $106,152 | $107,354 | $107,459 |
| SG&A Expenses | $263,932 | $259,467 | $252,415 | $264,802 |
| Sales & Mktg Exp. | $155,723 | $153,315 | $145,061 | $157,343 |
| Other Operating Expenses | $33,756 | $22,552 | $395,294 | $25,925 |
| Operating Expenses | $297,688 | $282,019 | $647,709 | $290,727 |
| Operating Income | $336,775 | $342,429 | -$22,415 | $329,919 |
| % Margin | 29.6% | 30.4% | -2% | 30.4% |
| Other Income/Exp. Net | -$52,586 | -$66,404 | -$71,500 | -$67,461 |
| Pre-Tax Income | $284,189 | $276,025 | -$93,915 | $262,458 |
| Tax Expense | $69,584 | $66,686 | -$11,609 | $57,077 |
| Net Income | $214,605 | $209,339 | -$82,306 | $205,381 |
| % Margin | 18.9% | 18.6% | -7.3% | 18.9% |
| EPS | 4.32 | 4.21 | -1.65 | 4.09 |
| % Growth | 2.6% | 355.2% | -140.3% | – |
| EPS Diluted | 4.29 | 4.17 | -1.65 | 4.04 |
| Weighted Avg Shares Out | 49,697 | 49,757 | 49,882 | 50,259 |
| Weighted Avg Shares Out Dil | 50,080 | 50,178 | 49,889 | 50,842 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $47,632 | $67,160 | $69,164 | $64,287 |
| Depreciation & Amortization | $30,173 | $30,675 | $32,625 | $32,092 |
| EBITDA | $361,994 | $373,860 | $7,874 | $358,837 |
| % Margin | 31.8% | 33.2% | 0.7% | 33% |